Development of a Standardized Parenteral Nutrition Protocol for the Obese Population

Persistent Link:
http://hdl.handle.net/10150/614001
Title:
Development of a Standardized Parenteral Nutrition Protocol for the Obese Population
Author:
Ly, Eric T.; Mirgeler, Scott N.; Rollins, Carol J.; Matthias, Kathryn R.
Affiliation:
College of Pharmacy, The University of Arizona
Issue Date:
2016
Rights:
Copyright © is held by the author.
Collection Information:
This item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Associate Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.
Publisher:
The University of Arizona.
Abstract:
Objectives: To determine if obese patients receiving parenteral nutrition (PN) require an increased amount of potassium, magnesium, and phosphorus electrolyte provisions compared to non-obese patients. Methods: The project design was an institutional review board-approved, retrospective, descriptive chart review. Electronic medical records and physical parenteral nutrition order cards were accessed to identify patients who met the inclusion and exclusion criteria of the study. The total amounts of potassium, phosphorous, and magnesium received by patients over the initial seven days of PN therapy were calculated. The Chi-squared and independent t-tests were utilized to evaluate the statistical significance for all nominal and interval data respectively. Results: 112 samples met the inclusion criteria of the study. There were 75 samples in the non-obese group (mean age=55.1 years, mean BMI=22 kg/m2, 53% female), and 37 samples in the obese group (mean age=57.1 years, mean BMI=33.8 kg/m2, 51% female). The daily average and seven-day totals of potassium, magnesium, and phosphorus did not significantly differ between the non-obese and obese groups (average daily potassium (P=0.6224), weekly total potassium (P=0.7551), average daily magnesium (P=0.8068), weekly total magnesium (P=0.3863), average daily phosphorus (P=0.9698), weekly total phosphorus (P=0.0603)). Conclusions: Potassium, magnesium, and phosphorus electrolyte provisions administered through PN over a week appear to be similar for both non-obese and obese patients. Our study results indicate that the same standard set for dosing initial PN electrolyte provisions in a non-obese patient may be applied to dosing similar provisions for an obese patient.
Description:
Class of 2016 Abstract
Keywords:
Development; parenteral nutrition; protocol; obese
Advisor:
Rollins, Carol J.; Matthias, Kathryn R.

Full metadata record

DC FieldValue Language
dc.contributor.advisorRollins, Carol J.en
dc.contributor.advisorMatthias, Kathryn R.en
dc.contributor.authorLy, Eric T.en
dc.contributor.authorMirgeler, Scott N.en
dc.contributor.authorRollins, Carol J.en
dc.contributor.authorMatthias, Kathryn R.en
dc.date.accessioned2016-06-21T21:34:00Z-
dc.date.available2016-06-21T21:34:00Z-
dc.date.issued2016-
dc.identifier.urihttp://hdl.handle.net/10150/614001-
dc.descriptionClass of 2016 Abstracten
dc.description.abstractObjectives: To determine if obese patients receiving parenteral nutrition (PN) require an increased amount of potassium, magnesium, and phosphorus electrolyte provisions compared to non-obese patients. Methods: The project design was an institutional review board-approved, retrospective, descriptive chart review. Electronic medical records and physical parenteral nutrition order cards were accessed to identify patients who met the inclusion and exclusion criteria of the study. The total amounts of potassium, phosphorous, and magnesium received by patients over the initial seven days of PN therapy were calculated. The Chi-squared and independent t-tests were utilized to evaluate the statistical significance for all nominal and interval data respectively. Results: 112 samples met the inclusion criteria of the study. There were 75 samples in the non-obese group (mean age=55.1 years, mean BMI=22 kg/m2, 53% female), and 37 samples in the obese group (mean age=57.1 years, mean BMI=33.8 kg/m2, 51% female). The daily average and seven-day totals of potassium, magnesium, and phosphorus did not significantly differ between the non-obese and obese groups (average daily potassium (P=0.6224), weekly total potassium (P=0.7551), average daily magnesium (P=0.8068), weekly total magnesium (P=0.3863), average daily phosphorus (P=0.9698), weekly total phosphorus (P=0.0603)). Conclusions: Potassium, magnesium, and phosphorus electrolyte provisions administered through PN over a week appear to be similar for both non-obese and obese patients. Our study results indicate that the same standard set for dosing initial PN electrolyte provisions in a non-obese patient may be applied to dosing similar provisions for an obese patient.en
dc.language.isoen_USen
dc.publisherThe University of Arizona.en
dc.rightsCopyright © is held by the author.en
dc.subjectDevelopmenten
dc.subjectparenteral nutritionen
dc.subjectprotocolen
dc.subjectobeseen
dc.titleDevelopment of a Standardized Parenteral Nutrition Protocol for the Obese Populationen_US
dc.typetexten
dc.typeElectronic Reporten
dc.contributor.departmentCollege of Pharmacy, The University of Arizonaen
dc.description.collectioninformationThis item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Associate Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.en
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.